For those ILD cases exposed to methotrexate concomitantly, drug causality assessment can be difficult. A meta-analysis in 2018 'did not reveal an increase in the risk of non-infectious respiratory AEs in adult patients with RA who were treated with tocilizumab compared with other DMARDs' (PMID 30183597)

Last update : 10/10/2018